Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
Cash Flow Statement
Cash Flow Statement
Clarus Therapeutics Holdings Inc
Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | ||
---|---|---|---|---|---|---|
Operating Cash Flow | ||||||
Net Income |
15
|
(29)
|
(36)
|
(41)
|
(66)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
|
Other Non-Cash Items |
(65)
|
(44)
|
(1)
|
4
|
11
|
|
Cash Interest Paid |
3
|
3
|
3
|
0
|
6
|
|
Change in Working Capital |
8
|
9
|
(3)
|
(7)
|
(6)
|
|
Cash from Operating Activities |
(42)
N/A
|
(64)
-52%
|
(40)
+36%
|
(44)
-8%
|
(61)
-39%
|
|
Investing Cash Flow | ||||||
Capital Expenditures |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Cash from Investing Activities |
0
N/A
|
(0)
N/A
|
(0)
+75%
|
(0)
-19%
|
(0)
-40%
|
|
Financing Cash Flow | ||||||
Net Issuance of Common Stock |
0
|
0
|
0
|
14
|
0
|
|
Net Issuance of Debt |
0
|
76
|
32
|
32
|
32
|
|
Other |
(4)
|
(4)
|
17
|
17
|
0
|
|
Cash from Financing Activities |
47
N/A
|
72
+53%
|
49
-32%
|
63
+28%
|
63
+0%
|
|
Change in Cash | ||||||
Net Change in Cash |
5
N/A
|
9
+62%
|
9
+2%
|
19
+118%
|
2
-89%
|
|
Free Cash Flow | ||||||
Free Cash Flow |
(42)
N/A
|
(64)
-52%
|
(40)
+36%
|
(44)
-8%
|
(61)
-39%
|